Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for MannKind
Company Monitoring Page for MannKind
latest headlines for company on cafepharma
The Little Company That Couldn't: Why No One Cares About MannKind's Potential Diabetes Blockbuster
BNET Pharma
Thu, 05/20/10 - 06:32 pm
Tags:
MannKind
,
diabetes
,
inhaled insulin
Mannkind: Afrezza Efficacy Insufficient, Says Hapoalim
Barron's
Tue, 05/18/10 - 09:32 pm
Tags:
MannKind
,
Afrezza
,
diabetes
,
inhaled insulin
MannKind Corporation Q1 2010 Earnings Call Transcript
Seeking Alpha
Sat, 05/1/10 - 10:33 am
Tags:
MannKind
,
earnings
Mannkind's Afrezza Seems Short of Breath
Seeking Alpha
Fri, 04/30/10 - 07:47 am
Tags:
Eli Lilly
,
Afrezza
,
MannKind
,
diabetes
,
inhaled insulin
,
Pfizer
,
Novo Nordisk
Follow-up Safety Data Show AFREZZA Comparable to Standard Antidiabetic Therapy in Lung Function Tests
Yahoo/BusinessWire
Sat, 04/24/10 - 01:01 pm
Tags:
MannKind
,
Afrezza
,
diabetes
More Delays on MannKind's Inhaled Insulin: The Pros and Cons
BNET Pharma
Thu, 03/18/10 - 08:15 am
Tags:
MannKind
,
inhaled insulin
,
diabetes
,
Afrezza
MannKind’s Insulin Afrezza Fails to Win Approval
Bloomberg
Mon, 03/15/10 - 11:57 am
Tags:
MannKind
,
inhaled insulin
,
Afrezza
,
FDA
10 Biotech Stocks On the Line
TheStreet.com
Thu, 03/11/10 - 08:57 am
Tags:
Medivation
,
InterMune
,
Allos
,
Affymax
,
Amylin
,
Alkermes
,
Cell Therapeutics
,
Delcath
,
Dendreon
,
GenVec
,
MannKind
,
Somaxon
,
Vertex Pharmaceuticals
For Biotech in 2010, It's Déjà Vu All Over Again
Seeking Alpha
Mon, 03/8/10 - 10:23 am
Tags:
Alkermes
,
Amylin
,
MannKind
,
Cell Therapeutics
,
Dendreon
,
Isis Pharmaceuticals
,
Amag Pharmaceuticals
,
XenoPort
,
Novelos Therapeutics
,
Adventrx
,
Delcath
If Approved -- FDA Drug Labeling Could Decide Ultimate Success of MannKind's Afrezza
BNET Pharma
Wed, 01/20/10 - 09:13 am
Tags:
MannKind
,
Afrezza
,
inhaled insulin
,
diabetes
Biotech Stock Mailbag: Adventrx Pharmaceuticals
TheStreet.com
Fri, 01/15/10 - 09:21 am
Tags:
Cord Blood America
,
Adventrx
,
Novelos Therapeutics
,
MannKind
,
Hemispherx
,
Cell Therapeutics
MannKind expects FDA to approve inhaled insulin
Reuters
Thu, 01/14/10 - 09:05 am
Tags:
inhaled insulin
,
MannKind
,
FDA
,
Afresa
,
Afrezza
[video]Diabetes Setback
Yahoo/CNBC
Tue, 01/12/10 - 08:59 pm
Tags:
MannKind
,
inhaled insulin
,
diabetes
FDA to Blame for Mannkind Delay?
TheStreet.com
Mon, 01/11/10 - 09:16 am
Tags:
FDA
,
MannKind
,
Afrezza
,
inhaled insulin
MannKind Updates Status of New Drug Application
Yahoo/BusinessWire
Sat, 01/9/10 - 11:23 am
Tags:
MannKind
,
insulin
Biotech Stock Mailbag: Novelos Therapeutics and more
TheStreet.com
Fri, 01/8/10 - 11:20 am
Tags:
Poniard
,
Novelos Therapeutics
,
MannKind
,
Dendreon
,
Cell Therapeutics
,
BioDelivery Sciences
,
Biocryst
Biotech Drugs to Watch In 2010
Minyanville
Thu, 01/7/10 - 11:14 am
Tags:
Arena Pharmaceuticals
,
Vivus
,
Orexigen
,
Novo Nordisk
,
Amylin
,
Eli Lilly
,
Biogen Idec
,
Acorda Therapeutics
,
Dendreon
,
MannKind
MannKind shares gain ground ahead of FDA decision
Yahoo/AP
Thu, 01/7/10 - 09:51 am
Tags:
FDA
,
MannKind
,
inhaled insulin
,
Afresa
2010 FDA Decisions to Watch
Motley Fool
Sun, 01/3/10 - 11:39 am
Tags:
FDA
,
Pfizer
,
Nektar
,
MannKind
,
Afresa
,
Eli Lilly
,
Amylin
,
Dendreon
,
Vivus
,
Alkermes
,
Arena Pharmaceuticals
,
Orexigen
Biotech Calendar: Upcoming FDA Dates
TheStreet.com
Tue, 12/15/09 - 08:54 am
Tags:
FDA
,
Dendreon
,
Arena Pharmaceuticals
,
Chelsea Therapeutics
,
Cephalon
,
Biodel
,
Auxilium
,
Novartis
,
Novo Nordisk
,
Shire
,
Vivus
,
MannKind
,
Acorda Therapeutics
Pages
« first
‹ previous
…
17
18
19
20
21
22
23
24
25
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.